Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

NCT05014399 is registered in ClinicalTrials.gov with Joseph McCollom as lead sponsor.

NCT NCT05014399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Lead sponsor
Joseph McCollom
Phase
Observational
Overall status
Recruiting
Start date
September 20, 2021
Completion date
October 31, 2031
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemo fog, chemo-brain, chemotherapy effect, cognitive change, cognitive decline, cognitive dysfunction, cognitive impairment, neoplasm, colorectal